
Philippines: Reiteration Against Unethical Business Practices Related To The Promotion Of Prescription Pharmaceutical Products And Medical Devices (PPPMD)
The Philippines Food and Drug Administration (FDA) issued an Advisory No. 2022-2045 on 29 December 2022, to warn all Prescription Pharmaceutical Products and Medical Devices (PPPMD) companies, and healthcare professionals (HCPs) not to engage in unethical business practices as mentioned in the provisions of Administrative Order (AO) No. 2015-0053 entitled




